1. Home
  2. TVRD vs EWCZ Comparison

TVRD vs EWCZ Comparison

Compare TVRD & EWCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • EWCZ
  • Stock Information
  • Founded
  • TVRD 2017
  • EWCZ 2004
  • Country
  • TVRD United States
  • EWCZ United States
  • Employees
  • TVRD N/A
  • EWCZ N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • EWCZ Package Goods/Cosmetics
  • Sector
  • TVRD Health Care
  • EWCZ Consumer Discretionary
  • Exchange
  • TVRD Nasdaq
  • EWCZ Nasdaq
  • Market Cap
  • TVRD 246.5M
  • EWCZ 239.2M
  • IPO Year
  • TVRD N/A
  • EWCZ 2021
  • Fundamental
  • Price
  • TVRD $40.68
  • EWCZ $3.56
  • Analyst Decision
  • TVRD Strong Buy
  • EWCZ Hold
  • Analyst Count
  • TVRD 5
  • EWCZ 6
  • Target Price
  • TVRD $59.20
  • EWCZ $5.50
  • AVG Volume (30 Days)
  • TVRD 67.6K
  • EWCZ 498.4K
  • Earning Date
  • TVRD 11-21-2025
  • EWCZ 11-13-2025
  • Dividend Yield
  • TVRD N/A
  • EWCZ N/A
  • EPS Growth
  • TVRD N/A
  • EWCZ N/A
  • EPS
  • TVRD N/A
  • EWCZ 0.20
  • Revenue
  • TVRD N/A
  • EWCZ $212,509,000.00
  • Revenue This Year
  • TVRD N/A
  • EWCZ N/A
  • Revenue Next Year
  • TVRD N/A
  • EWCZ $2.27
  • P/E Ratio
  • TVRD N/A
  • EWCZ $17.87
  • Revenue Growth
  • TVRD N/A
  • EWCZ N/A
  • 52 Week Low
  • TVRD $8.13
  • EWCZ $2.72
  • 52 Week High
  • TVRD $42.10
  • EWCZ $8.91
  • Technical
  • Relative Strength Index (RSI)
  • TVRD 70.68
  • EWCZ 34.79
  • Support Level
  • TVRD $36.05
  • EWCZ $3.72
  • Resistance Level
  • TVRD $42.10
  • EWCZ $4.00
  • Average True Range (ATR)
  • TVRD 2.87
  • EWCZ 0.19
  • MACD
  • TVRD 0.07
  • EWCZ -0.02
  • Stochastic Oscillator
  • TVRD 82.26
  • EWCZ 2.07

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About EWCZ European Wax Center Inc.

European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.

Share on Social Networks: